Xencor | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Arrowhead Research USD -161412000 791K 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Cytokinetics USD -139040000 1.76M 2024-12
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
J&J USD 13.63B 9.74B 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Xencor USD 4.05M 66.33M 2024-12



Xencor L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.